The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - U and I Group PLC

12 Nov 2021 07:00

RNS Number : 1616S
U and I Group PLC
12 November 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

U and I Group PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

U and I Group PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

11 November 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 50 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests in U and I Group PLC's ordinary shares held by the directors of U and I Group PLC and their close relatives and related trusts

 

Class of relevant securities:

Ordinary shares of 50 pence each

Director Name

Number of U and I Group PLC ordinary shares

Percentage of total issued share capital (excl. share options)

Peter Williams

175,941(1)

0.1403%

Richard Upton

4,254,384

3.3918%

Jamie Christmas

20,860

0.0166%

Lynette Krige

12,605

0.0100%

Barry Bennett

53,352

0.0425%

Rosaleen Kerslake

13,031

0.0104%

Sadie Morgan

25,441

0.0203%

(1) Includes 48,000 ordinary shares held by Gwendolen Anita Knight, a close relative of Peter Williams

 

(b) Interests held as options or awards under the share plans of U and I Group PLC by the directors of U and I Group PLC and their close relatives and related trusts

 

Name

Scheme

Date of grant

Number of U and I Group PLC ordinary shares under option

Exercise period/vesting date

Exercise price (pence)

Richard Upton

U+I Long Term Incentive Plan

28 June 2021

179,598

3 years

Nil cost option

U+I Long Term Incentive Plan

28 June 2021

179,597

4 years

Nil cost option

U+I Long Term Incentive Plan

5 August 2020

577,008

3 years

Nil cost option

U+I Long Term Incentive Plan

5 August 2020

577,007

4 years

Nil cost option

U+I Long Term Incentive Plan

21 November 2019

365,091

3 years

Nil cost option

U+I Long Term Incentive Plan

21 November 2019

365,090

4 years

Nil cost option

U+I Long Term Incentive Plan

7 June 2018

214,724

4 years

Nil cost option

Jamie Christmas

U+I Long Term Incentive Plan

28 June 2021

153,941

3 years

Nil cost option

U+I Long Term Incentive Plan

28 June 2021

153,940

4 years

Nil cost option

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

12 November 2021

Contact name:

Chris Barton, Company Secretary

Telephone number:

+44 20 7828 4777

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFFLLFFFLFFBD
Date   Source Headline
26th Apr 20177:00 amRNSResults for the year ended 28 February 2017
10th Apr 20177:00 amRNSBlock listing Interim Review
8th Mar 20177:00 amRNSDevelopment & trading gains in line with guidance
18th Jan 20177:00 amRNSU+I, joint venture with Colony NorthStar Inc.
21st Dec 201612:27 pmRNSDirector/PDMR Shareholding
15th Dec 20164:01 pmRNSBlock listing Interim Review
13th Dec 20163:52 pmRNSHolding(s) in Company
25th Nov 20164:53 pmRNSHolding(s) in Company
24th Nov 20167:00 amRNSBlock listing Interim Review
21st Nov 20167:05 amRNSInvestor Site Visit
21st Nov 20167:00 amRNSU+I, Sale of Elizabeth House (Woking)
11th Nov 20165:18 pmRNSHolding(s) in Company
7th Nov 20163:09 pmRNSDirector/PDMR Shareholding
31st Oct 20167:00 amRNSU+I SECURES LEASE ON LANDMARK VERTIUM BUILDING
24th Oct 201611:52 amRNSDirector/PDMR Shareholding
20th Oct 20163:28 pmRNSDirector/PDMR Shareholding
20th Oct 201610:35 amRNSDirector/PDMR Shareholding
19th Oct 20167:00 amRNSInterim Results
10th Oct 20167:00 amRNSBlock listing Interim Review
28th Sep 20169:00 amRNSNotice of Results
26th Sep 20163:00 pmRNSU+I update on development of a specialist platform
26th Sep 201611:26 amRNSHolding(s) in Company
19th Sep 20167:00 amRNSU+I wins GBP850m Manchester regeneration project
14th Sep 20164:46 pmRNSHolding(s) in Company
16th Aug 20167:00 amRNSU+I secures development site in North East London
12th Aug 20163:23 pmRNSDirector/PDMR Shareholding
10th Aug 20163:12 pmRNSDirector/PDMR Shareholding
14th Jul 20164:37 pmRNSResult of AGM
1st Jul 20165:04 pmRNSDirector/PDMR Shareholding
20th Jun 201610:52 amRNSDirector/PDMR Shareholding
16th Jun 201612:01 pmRNSBlock listing Interim Review
14th Jun 20167:00 amRNSDirector/PDMR Shareholding
8th Jun 201610:59 amRNSDirector/PDMR Shareholding
31st May 20163:46 pmRNSTotal Voting Rights
31st May 20163:44 pmRNSDirector/PDMR Shareholding
20th May 20165:11 pmRNSAnnual Financial Report
19th May 20162:33 pmRNSAdditional Listing
17th May 201610:38 amRNSDirector/PDMR Shareholding
12th May 201610:46 amRNSHolding(s) in Company
4th May 20162:39 pmRNSDirector/PDMR Shareholding
3rd May 20164:08 pmRNSHolding(s) in Company
28th Apr 20167:00 amRNSPreliminary Results
15th Apr 20165:27 pmRNSHolding(s) in Company
15th Apr 20167:00 amRNSHolding(s) in Company
11th Apr 20167:00 amRNSBlock listing Interim Review
8th Apr 20167:00 amRNSNotice of Final Results
6th Apr 201610:02 amRNSHolding(s) in Company
16th Mar 201610:46 amRNSHolding(s) in Company
15th Mar 20167:00 amRNSDeptford completion realises profits of GBP4.0m
14th Mar 20167:00 amRNSFirst phase of 399 Edgware Road completes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.